Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,108 | 1,355 | 13,100 | 10,378 | 2,921 |
| Receivables | N/A | N/A | 300 | N/A | N/A |
| Other current assets | 134 | 0 | 0 | 0 | 0 |
| TOTAL | $104,118 | $1,580 | $13,629 | $11,023 | $3,378 |
| Non-Current Assets | |||||
| PPE Net | 367 | 210 | 313 | 207 | 287 |
| Other Non-Current Assets | 3,796 | 3,983 | 70 | 48 | 48 |
| TOTAL | $4,164 | $4,192 | $383 | $255 | $334 |
| Total Assets | $108,281 | $5,772 | $14,012 | $11,278 | $3,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 838 | 1,837 | 1,055 | 1,196 | 867 |
| Accrued Expenses | 1,563 | 562 | 1,686 | 206 | 443 |
| TOTAL | $4,189 | $2,771 | $2,801 | $1,459 | $1,368 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,420 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 9,624 | 8,727 | 3,748 | 2,608 | 1,578 |
| TOTAL | $12,114 | $8,730 | $4,136 | $2,903 | $1,729 |
| Total Liabilities | $16,303 | $11,502 | $6,937 | $4,362 | $3,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,373 | 1,857 | 1,419 | 767 | 310 |
| Common Shares | 181 | 49 | 43 | 23 | 9 |
| Retained earnings | -219,842 | -201,907 | -181,133 | -156,544 | -141,999 |
| Other shareholders' equity | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $91,979 | $-5,729 | $7,075 | $6,917 | $616 |
| Total Liabilities And Equity | $108,281 | $5,772 | $14,012 | $11,278 | $3,712 |